James R Meyers's Net Worth

$11.7 Million

Estimate Recalculated Nov 8, 2024 04:31PM EST

Who is James R Meyers?

James R Meyers has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES INC, SANGAMO THERAPEUTICS, INC, Arbutus Biopharma Corp, and CytomX Therapeutics, Inc..

SEC CIK

James R Meyers's CIK is 0001387521

Past Insider Trading and Trends

2017 was James R Meyers's most active year for acquiring shares with 9 total transactions. James R Meyers's most active month to acquire stocks was the month of January. 2007 was James R Meyers's most active year for disposing of shares, totalling 18 transactions. James R Meyers's most active month to dispose stocks was the month of March. 2018 saw James R Meyers paying a total of $2,171,278.80 for 254,138 shares, this is the most they've acquired in one year. In 2018 James R Meyers cashed out on 203,970 shares for a total of $8,157,260.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GILEAD SCIENCES INC (GILD) Snapshot price: $78.52

EVP Worldwide Commercial Ops

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.78%
5K
$71.52
-$119,117.63
137.48K
Feb 15 - Feb 21
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
$50.91
-$5,866,863.57
2.71K
Scheduled
Jan 16
Form 4
+1.01%
1.33K
$73.02
-$100,256.46
132.47K
Nov 9
Form 4
+1.78%
2.29K
$73.46
-$162,493.52
131.15K
Nov 5
Form 4
—
0
$52.10
-$3,731,289.50
2.71K
Aug 31
Form 4
+0.09%
115
$59.76
$6,872.80
128.86K
Aug 15
Form 4
+0.41%
525
$72.70
-$21,446.50
128.75K
Aug 10
Form 4
+0.27%
343
$64.82
-$131,709.14
128.22K
Feb 15 - Feb 16
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Dec 10
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
$45.29
-$681,997.09
1.03K
Apr 24
Form 4
—
0
$39.78
-$378,822.00
1.03K
Feb 28
Form 4
—
0
—
—
0
Jan 22
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.40%
25K
—
—
74.6K
Jun 4
Form 4
+38.94%
13.9K
—
—
49.6K
Jun 1
Form 4
+53.88%
12.5K
—
—
35.7K
Feb 25
Form 4
+54.67%
8.2K
—
—
23.2K
Feb 25
Form 4/A
+200.00%
10K
—
—
15K
May 18
Form 4
+50.00%
2.5K
—
—
7.5K
May 18
Form 4
∞
5K
—
—
5K
Nov 22
Form 3
—
0
—
—
0
No matching records found

Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
Oct 18
Form 3
—
0
—
—
0
No matching records found

CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Dec 20
Form 3
—
0
—
—
0
No matching records found